MALAT-1 was initially identified in patients with non-small cell lung cancer (NSCLC), and subsequent investigations revealed its upregulation in tumors displaying a pronounced metastatic potential [37]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.